Mark Cuban: Insurance CEOs Are Better at Extracting Money from Taxpayers than the Government
Investor Mark Cuban responded to a tweet about "government efficiency" by arguing that insurance company CEOs are actually "much smarter" than most government officials in their ability to extract money from taxpayers, far surpassing the government's level of "wasting money." His viewpoint continues a long-standing criticism of the structure of the insurance, PBM, and self-insured employer markets.
English policy and business analysis also show that the U.S. health insurance and pharmacy benefit management (PBM) systems extract significant hidden profits from government, employers, and patient budgets through complex price differences, rebates, prescription rules, and contract terms. These intermediary profits often present themselves in forms like "reimbursement rates" and "risk adjustments," which are more concealed and expandable than the government’s publicly disclosed "linear spending."
In this structure, the government acts more like a provider and regulator of a "seed funding pool," while the real "calculating" executors are the insurance and PBM operators. This allows Cuban to firmly anchor the fiscal funnel at the corporate level with the comparison of "extraction vs. waste."
Source: Public Information
ABAB AI Insight
Cuban's assertion effectively shifts the critique of "healthcare efficiency" from "how much money is spent" to "who is taking the money." Traditional criticisms have focused on government budget overruns, bureaucratic expansion, and poor project execution, while he points the finger at the corporate structure where insurance companies and PBMs, through rule design, negotiation power, and information asymmetry, turn public funds and employer payments into re-marketable, re-securitized streams of intermediary profits.
In terms of incentive structures, this creates an "inverted responsibility chain": the government and employers are responsible for payments, hospitals and doctors for execution, while insurance and PBMs, as "rule makers," embed risk pricing, prescription reviews, and reimbursement structures as profit engines. This design means that the more complex the regulation, the more reimbursement rules, and the higher the risk stratification, the more gaps are created for intermediaries to optimize, rather than creating more value for patients.
From a long-term structural perspective, this model also makes "reform" more difficult: the government wants to cut budgets while maintaining universal coverage, leading to a tug-of-war between "increasing insurance regulation" and "reducing government spending." Meanwhile, the truly profitable intermediaries can often shift pressure onto hospitals, patients, and employers through lobbying, contract restructuring, and interest redistribution, thereby consolidating their position amid systemic turmoil. Cuban's judgment of "smarter" is less a compliment and more a clear naming of a highly entrenched predatory structure.